Glial cell abnormalities in major psychiatric disorders: The evidence and implications

Brain Research Bulletin

Volumn 55, Issue 5, 2001, Pages 585-595

  Cotter, David R ^a   Pariante, Carmine M ^a   Everall, Ian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorder; Depression; Glia; Glucocorticoids; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; NEUROTROPHIC FACTOR;

AFFECTIVE NEUROSIS; ALEXITHYMIA; ASTROCYTE; CELL METABOLISM; DEPRESSION; FRONTAL CORTEX; GLIA CELL; GLIOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MENTAL DISEASE; NEUROPATHOLOGY; NEUROTRANSMISSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPSE;

CELL DEATH; CEREBRAL CORTEX; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NERVE DEGENERATION; NEUROGLIA; PSYCHOTROPIC DRUGS;

EID: 0035878167     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00527-5     Document Type: Review

References (125)

1. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia; Assessment with xenon 133 single-photon emission computed tomography and the Tower of London
2. Tripartite synapses; Glia, the unacknowledged partner
3. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons
4. Recent advances in defining the neuropathology of schizophrenia
5. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia
6. Evidence for activation of microglia in patients with psychiatric illness
7. Changes in regional cerebral blood flow on recovery from depression
8. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics
9. Deficits in small interneurons in prefrontal and cingulate cortices in schizophrenic and schizoaffective patiants
10. Emerging principles of altered neural circuitry in schizophrenia
11. Modulation of N-methyl-D-aspartate receptor function by glycine transport
12. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate (NAAG); Subcellular and regional distribution, ontogeny and effects of lesions on nNAALADase
13. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
14. Hippocampal remodelling and damage by corticosteroids; Implications for mood disorders
15. Schizophrenia and the brain; A prospective cliniconeuropathological study
16. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II
17. The neuroendocrinology of depression and chronic stress
18. Signalling from neurones to glial cells in invertebrates
19. The role of neuronal growth factors in neurodegenerative disorders of the human brain
20. Reduced glial cell density and neuronal volume in major depression in the anterior cingulate cortex
21. Mind glue; Implications of glial cell biology for psychiatry
22. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation
23. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and proposal concerning the genetic basis of the disease
24. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients; Preliminary findings
25. A molecular and cellular theory of depression
26. The role of the cingulate gyrus in depression; From functional anatomy to neurochemistry
27. Molecular profile of reactive astrocytes-Implications for their role in neurologic disease
28. The dexamethasone suppression test. A review
29. Cell loss in the hippocampus
30. Limbic pathology in schizophrenia; The entorhinal region-a morphometric study
31. No evidence for astrogliosis in brains of schizophrenic patients. A postmortem study
32. Non-competitive antagonism of N-methyl-D-aspartate by displacement of an endogenous glycine-like substance
33. Studies on the disposition of quinlinic acid after intracerebral or systemic administration in the rat
34. Gonadal hormones as promotypes of structural synaptic plasticity; Cellular mechanisms
35. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair
36. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia
37. Reductions of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia
38. Activation of cultured glial cells by amitryptilene and platelet activating factor
39. Estrogen receptor immunoreactivity in Schwann-like brain macroglia
40. Preferential involvement of excitatory neurons in the medial temporal lobe in schizophrenia
41. The neuropathology of schizophrenia; A critical review of the data and their interpretation
42. Evidence for glutamate mediated activation of hippocampal neurons by glial calcium waves
43. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness
44. Microglial reactivity correlates to the density and the myelination of the anterogradely degenerating axons and terminals following perforant path denervation of the mouse fascia dentata
45. Glycine potentiates the NMDA response in cultured mouse brain neurons
46. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder and major depressive disorder
47. Glia as mediators of steroid hormone action on the nervous system; An overview
48. Local cerebral glucose utilisation is increased in acutely adrenalectomised rats
49. Superior temporal gyrus and the course of early schizophrenia; Progressive, static or reversible?
50. Glial cell loss in the hippocampus of alcoholics
51. Microglia; A sensor for pathological events in the CNS
52. Glial fibrillary acidic protein; Regulation by hormones, cytokines and growth factors
53. Brain abnormality in schizophrenia; A systematic and quantitative review of volumetric magnetic resonance imaging studies
54. Brain structure change and psychopathology in subjects at high risk of schizophrenia
55. Neurotrophic factors; From molocule to man
56. Association between brain size and abstinence from alcohol
57. Energy on demand
58. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain
59. Glucocorticoids up-regulate the expression of glial fibrillary acidic protein in the rat suprachiasmatic nucleus
60. Mood and neuropsychological function in depression; The role of corticosteroids and serotonin
61. MRI anatomy of schizophrenia
62. Possible mechanisms for atrophy of the human hippocampus
63. Glial contributions to excitatory neurotransmission in cultured hippocampal cells
64. Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1
65. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder
66. Myelin-associated inhibitors of neurite growth
67. Neurotrophins regulate the function of cultured microglia
68. The corticotropin-releasing factor (CRF) hypothesis of depression; New findings and new directions
69. Regulation of BDNF nd trkB mRNA in rat brain by chronic electroconvulsive and antidepressant drug treatments
70. Glial responses to steroids as markers of brain aging
71. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones
72. Glutamate receptor dysfunction and schizophrenia
73. Glial reduction in the subgenual prefrontal cortex in mood disorders
74. Ultrastructural dystrophic changes of oligodendroglial cells in autopsied prefrontal cortex and striatum in schizophrenia; A morphometric study
75. Decreased numerical density of oligodendroglial density cells in the prefrontal cortex area 9 in schizophrenia and mood disorders; A study of brain collection from the Stanley Foundation Neuropathology Consortium
76. Selective decreases in MAO-B activity in postmortem brains from schizophrenic patients with type II syndrome
77. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics
78. Left medial temporal lobe volume reduction occurs during the transition from high risk to first episode psychosis
79. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine
80. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia
81. New views on synapse-glia interactions
82. Synaptic efficacy enhanced by glial cells in vitro
83. Stress hormones and brain aging; Adding injury to insult
84. Differential effects of antidepressants on the viability of clonal hippocampal cells
85. Increased HLA-DR immunoreactive glia in frontal and temporal cortex of chronic schizophrenia
86. Glial and neuronal pathology in rostral orbitofrontal cortex in schizophrenic postmortem brain
87. Reductions in glia distinguish orbitofrontal region from dorsolateral prefrontal cortex in schizophrenia
88. Morphometric evidence for neuronal and glial prefrontal pathology in major depression
89. Neuronal and glial somal size in the prefrontal cortex; A postmortem morphometric study of schizophrenia and huntington disease
90. Dysfunction of neural circuits involved in the pathophysiology of mood disorders; Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells
91. Specification of the cerebral cortical areas
92. Gliosis in schizophrenia; A survey
93. Is there gliosis in schizophrenia? Investigation of the temporal lobe
94. Lithium treatment causes gliosis and modifies the morphology of hippocampal astrocytes in rats
95. Chronic administration of lithium chloride increases immunodetectable glial fibrillary acidic protein in the rat hippocampus
96. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders
97. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
98. Glucocorticoids, stress and exacerbation of excitotoxic neuron death
99. Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus
100. An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons
101. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure
102. Abnormally high neuronal density in the schizophrenic cortex; A morphometric analysis of prefrontal area 9 and occipital area 17
103. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients-Application of a three dimensional, stereologic counting method
104. Antidepressant-like effect of brain-derived neurotrophic factor
105. On the production and disposition of quinolinic acid in rat brain and liver slices
106. Activation of microglia; A dangerous interlude in immune function in the brain
107. Structural neuroimaging and mood disorders; Recent findings, implications for classification, and future directions
108. Quantitative study of gliosis in schizophrenia and Huntington's Chorea
109. Neuropathology of schizophrenia
110. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome
111. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
112. Dexamethasone suppression test in schizophrenia; Relationship to symptomatology, ventricular enlargement and outcome
113. Metabolic coupling between glia and neurons
114. Electron microscopy of oligodendroglia in severe mental illness
115. Morphometric study of ultrastructural alterations of myelinated fibers in postmortem schizophrenic brains
116. Hippocampal volume in first episode psychoses and chronic schizophrenia; A high resolution magnetic resonance imaging study
117. Glial calcium; Homeostasis and signaling function
118. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes; Implications for glucocorticoid neurotoxicity
119. Functional neuroimaging studies of depression; The anatomy of melancholia
120. Alterations in the expression of phosphorylated glial fibrillary acidic proteins in the frontal cortex of individuals with schizophrenia, bipolar disorder, and depression
121. Implications of normal brain development for the pathogenesis of schizophrenia
122. Serine racemase; A glial enzyme synthesising D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission
123. Seizure activity causes elevation of endogenous extracellular kyenurenic acid in the rat brain